| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Megan E Barra, Ken Solt, Xin Yu, Brian L Edlo. Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2024-07-17. PMID:39019729. |
emerging evidence suggests that pharmacologic modulation of specific neurotransmitter systems, such as dopamine, promotes recovery of consciousness. |
2024-07-17 |
2024-07-20 |
Not clear |
| Xueqian Xiao, Wei Ni, Yang Yang, Qinhua Chen, Yulin Zhang, Yujie Sun, Qiming Liu, Guo-Jun Zhang, Qunfeng Yao, Shaowei Che. Platinum nanowires/MXene nanosheets/porous carbon ternary nanocomposites for in situ monitoring of dopamine released from neuronal cells. Talanta. vol 278. 2024-07-12. PMID:38996563. |
dopamine is an important neurotransmitter in the body and closely related to many neurodegenerative diseases. |
2024-07-12 |
2024-07-15 |
Not clear |
| Greatness O Olaitan, Mallikarjunarao Ganesana, Andrew Strohman, Wendy J Lynch, Wynn Legon, B Jill Vento. Focused Ultrasound Modulates Dopamine in a Mesolimbic Reward Circuit. bioRxiv : the preprint server for biology. 2024-07-09. PMID:38979318. |
dopamine is a neurotransmitter that plays a significant role in reward and motivation. |
2024-07-09 |
2024-07-12 |
Not clear |
| Pallavi Singh, Priyanka Agrawal, K P Sing. Prenatal exposure to vortioxetine and vilazodone: Impact on depressive- and anxiety-like behavioral manifestations in young rat offspring. Behavioural brain research. 2024-06-30. PMID:38945303. |
additionally, neurotransmitter (serotonin, dopamine, and nor-epinephrine) levels in the prefrontal cortex region of the brain were substantially reduced in exposed offspring. |
2024-06-30 |
2024-07-03 |
rat |
| Stephanie M Matt, Rachel Nolan, Samyuktha Manikandan, Yash Agarwal, Breana Channer, Oluwatofunmi Oteju, Marzieh Daniali, Joanna A Canagarajah, Teresa LuPone, Krisna Mompho, Kaitlyn Runner, Emily Nickoloff-Bybel, Benjamin Li, Meng Niu, Johannes C M Schlachetzki, Howard S Fox, Peter J Gaskil. Dopamine-driven Increase in IL-1β in Myeloid Cells is Mediated by Differential Dopamine Receptor Expression and Exacerbated by HIV. bioRxiv : the preprint server for biology. 2024-06-25. PMID:38915663. |
the catecholamine neurotransmitter dopamine is classically known for regulation of central nervous system (cns) functions such as reward, movement, and cognition. |
2024-06-25 |
2024-06-27 |
human |
| Vittorio Gallese, Martina Ardizzi, Francesca Ferron. Schizophrenia and the bodily self. Schizophrenia research. vol 269. 2024-06-15. PMID:38815468. |
despite the historically consolidated psychopathological perspective, on the one hand, contemporary organicistic psychiatry often highlights abnormalities in neurotransmitter systems like dysregulation of dopamine transmission, neural circuitry, and genetic factors as key contributors to schizophrenia. |
2024-06-15 |
2024-06-18 |
Not clear |
| Annaelle Zietz, Josefin E Kaufmann, Karin Wiesner, Sandro Kevin Fischer, Martina Wiegert, Wilma Dj Verhagen-Kamerbeek, Yannik Rottenberger, Anne Schwarz, Nils Peters, Henrik Gensicke, Friedrich Medlin, Jens Carsten Möller, Bartosz Bujan, Leo H Bonati, Marcel Arnold, Sabine Schaedelin, René M Müri, Lars G Hemkens, Patrik Michel, Philippe A Lyrer, Jeremia P Held, Gary A Ford, Andreas R Luft, Christopher Traenka, Stefan T Engelte. Enhancement of STroke REhabilitation with Levodopa (ESTREL): Rationale and design of a randomized placebo-controlled, double blind superiority trial. European stroke journal. 2024-06-10. PMID:38853524. |
dopamine is a neurotransmitter involved in motor learning, reward, and brain plasticity. |
2024-06-10 |
2024-06-14 |
Not clear |
| Tania Arora, Gaurav Sharma, Vikash Prashar, Randeep Singh, Arti Sharma, Harish Changotra, Jyoti Parkas. Mechanistic Evaluation of miRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson's Disease. Molecular neurobiology. 2024-06-01. PMID:38823001. |
pd is mainly caused by the demolition of the primary dopamine neurotransmitter secretory cells and dopaminergic or dopamine secretory neurons in the substantia nigra pars compacta of the midbrain, which are majorly responsible for motor functions. |
2024-06-01 |
2024-06-03 |
Not clear |
| Manxing Zou, Yulu Wu, Yudan Lan, Huanfang Xie, Haopeng Sun, Wenyuan Liu, Feng Feng, Xueyang Jian. Identification and optimization of nitrophenolic analogues as dopamine metabolic enzyme inhibitors for the treatment of Parkinson's disease. Bioorganic chemistry. vol 148. 2024-05-26. PMID:38797066. |
progressive loss of dopaminergic neurons leads to the depletion of the striatal neurotransmitter dopamine, which is the main cause of parkinson's disease (pd) motor symptoms. |
2024-05-26 |
2024-05-31 |
Not clear |
| Fulvio Lauretani, Francesco Giallauria, Crescenzo Testa, Claudia Zinni, Beatrice Lorenzi, Irene Zucchini, Marco Salvi, Raffaele Napoli, Marcello Giuseppe Maggi. Dopamine Pharmacodynamics: New Insights. International journal of molecular sciences. vol 25. issue 10. 2024-05-25. PMID:38791331. |
dopamine is a key neurotransmitter involved in physiological processes such as motor control, motivation, reward, cognitive function, and maternal and reproductive behaviors. |
2024-05-25 |
2024-05-27 |
human |
| Hao Wu, Qin Wen, Xin Luan, Weiwei Yang, Lei Guo, Gang We. Facile Synthesis of Fe-Doped, Algae Residue-Derived Carbon Aerogels for Electrochemical Dopamine Biosensors. Sensors (Basel, Switzerland). vol 24. issue 9. 2024-05-11. PMID:38732893. |
an abnormal level of dopamine (da), a kind of neurotransmitter, correlates with a series of diseases, including parkinson's disease, willis-ekbom disease, attention deficit hyperactivity disorder, and schizophrenia. |
2024-05-11 |
2024-05-27 |
Not clear |
| Shashi B Singh, Atit Tiwari, Maanya R Katta, Riju Kafle, Cyrus Ayubcha, Krishna H Patel, Yash Bhattarai, Thomas J Werner, Abass Alavi, Mona-Elisabeth Revhei. The utility of PET imaging in depression. Frontiers in psychiatry. vol 15. 2024-05-08. PMID:38711875. |
studies have revealed alterations in neurotransmitter systems such as serotonin, dopamine, gaba, and glutamate, which are linked to the pathophysiology of depression. |
2024-05-08 |
2024-05-27 |
Not clear |
| Zhichao Yu, Juan Tang, Chenyi Zeng, Yuan Gao, Di Wu, Yongyi Zeng, Xiaolong Liu, Dianping Tan. Shaping the Future of the Neurotransmitter Sensor: Tailored CdS Nanostructures for State-of-the-Art Self-Powered Photoelectrochemical Devices. ACS sensors. 2024-05-02. PMID:38693685. |
here, we reported a triple-engineered cds nanohierarchical structures (cds nhs) modification scheme including morphology, defective states, and heterogeneous structure to achieve precise monitoring of the neurotransmitter dopamine (da) in plasma and noninvasive body fluids. |
2024-05-02 |
2024-05-04 |
human |
| Wan-Yu Zhao, Ji-You Tan. [Research Progress in the Correlation Between Dopamine and Clinical Characterization of Narcolepsy]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. vol 46. issue 2. 2024-04-30. PMID:38686723. |
dopamine,a neurotransmitter ubiquitous in the body fluids,blood,and urine of mammals and humans,is responsible for regulating their functions and metabolism.the dopamine system is involved in the neurobiological mechanisms of narcolepsy in animals and humans.however,researchers have drawn different or even opposite conclusions when measuring the dopamine level in the cerebrospinal fluid of narcolepsy patients.studies have confirmed that the occurrence of narcolepsy is related to the irreversible loss of orexins.the autoimmune reaction caused by the interactions of environmental factors with genetic factors destroys the hypothalamic orexin neurons and reduces orexin secretion,thereby lowering the level of arousal.we introduce the research progress and current status of dopamine and clinical characterization of narcolepsy by reviewing more than 40 articles published from 1982 to 2023,aiming to provide a reference for studying the relationship between the dopamine level and clinical characterization of narcolepsy and searching for the biomarkers of type 2 narcolepsy. |
2024-04-30 |
2024-05-03 |
Not clear |
| Elena Predescu, Tudor Vaidean, Andreea-Marlena Rapciuc, Roxana Sipo. Metabolomic Markers in Attention-Deficit/Hyperactivity Disorder (ADHD) among Children and Adolescents-A Systematic Review. International journal of molecular sciences. vol 25. issue 8. 2024-04-27. PMID:38673970. |
synthesis revealed intricate links between adhd and altered amino acid metabolism, neurotransmitter dysregulation (especially dopamine and serotonin), oxidative stress, and the kynurenine pathway impacting neurotransmitter homeostasis. |
2024-04-27 |
2024-04-29 |
human |
| Ming Liu, Ping Deng, Guangyu Li, Haoling Liu, Junli Zuo, Wenwen Cui, Huixian Zhang, Xin Chen, Jingjing Yao, Xitian Peng, Lijun Peng, Jiao Liu, Wenting Zheng, Wei Yan, Ning Lua. Neurotoxicity of Combined Exposure to the Heavy Metals (Pb and As) in Zebrafish ( Toxics. vol 12. issue 4. 2024-04-26. PMID:38668505. |
to elucidate the underlying mechanisms, we examined changes in acetylcholinesterase (ache) activity, neurotransmitter (dopamine, 5-hydroxytryptamine) levels, hpi axis-related hormone (cortisol and epinephrine) contents and neurodevelopment-related gene expression in zebrafish brain. |
2024-04-26 |
2024-04-28 |
zebrafish |
| Susanna Molas, Timothy G Freels, Rubing Zhao-Shea, Timothy Lee, Pablo Gimenez-Gomez, Melanie Barbini, Gilles E Martin, Andrew R Tappe. Dopamine control of social novelty preference is constrained by an interpeduncular-tegmentum circuit. Nature communications. vol 15. issue 1. 2024-04-03. PMID:38570514. |
combining calcium and neurotransmitter sensors with fiber photometry and optogenetics in mice, we find that mesolimbic dopamine (da) neurotransmission is strongly and predominantly activated by social novelty controlling bout length of interaction during np, a response significantly reduced by familiarity. |
2024-04-03 |
2024-04-06 |
mouse |
| Maya Molinari, Ori J Lieberman, David Sulzer, Emanuela Santini, Anders Borgkvis. 5-HT1B receptors mediate dopaminergic inhibition of vesicular fusion and GABA release from striatonigral synapses. bioRxiv : the preprint server for biology. 2024-04-01. PMID:38559006. |
these d1rs are primarily located on the terminals of striatonigral medium spiny neurons, suggesting their involvement in the regulation of neurotransmitter release from the direct pathway in response to somatodendritic dopamine release. |
2024-04-01 |
2024-04-04 |
Not clear |
| Meghan L Bucher, Amy R Dunn, Joshua M Bradner, Kristen Stout Egerton, James P Burkett, Michelle A Johnson, Gary W Mille. Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity. The European journal of neuroscience. 2024-03-27. PMID:38532289. |
here, we adapted a previously published in vitro assay utilising false fluorescent neurotransmitter 206 (ffn206) to visualise how sv2c regulates vesicular dopamine dynamics and determined that sv2c promotes the uptake and retention of ffn206 within vesicles. |
2024-03-27 |
2024-03-29 |
mouse |
| Érica Novaes Soares, Ana Carla Dos Santos Costa, Gabriel de Jesus Ferrolho, Rodrigo Portes Ureshino, Bruk Getachew, Silvia Lima Costa, Victor Diogenes Amaral da Silva, Yousef Tizab. Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson's Disease. Cells. vol 13. issue 6. 2024-03-27. PMID:38534318. |
dopamine (da) is the primary neurotransmitter involved in this disease, but cholinergic imbalance has also been implicated. |
2024-03-27 |
2024-03-29 |
Not clear |